A Potential GSK Game Changer And An MRNA Cancer Vaccine: Highlights From The 2022 ASCO Conference

Österreich Nachrichten Nachrichten

A Potential GSK Game Changer And An MRNA Cancer Vaccine: Highlights From The 2022 ASCO Conference
Österreich Neuesten Nachrichten,Österreich Schlagzeilen
  • 📰 ForbesTech
  • ⏱ Reading Time:
  • 18 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 59%

I am a New York based health and science reporter and a graduate from Columbia’s School of Journalism with a master's in science and health reporting. I write on infectious diseases, global health, gene editing tools, intersection of public health and global warming. Previously, I worked as a health reporter in Mumbai, India, with the Hindustan Times, a daily newspaper where I extensively reported on drug resistant infections such as tuberculosis, leprosy and HIV. I also reported stories on medical malpractice, latest medical innovations and public health policies. I have a master’s in biochemistry and a bachelor’s degree in zoology. My experience of working in a molecular and a cell biology laboratory helped me see science from researcher's eye. In 2018 I won the EurekAlert! Fellowships for International Science Reporters. My Twitter account @aayushipratap

White House Mandates Pfizer Vaccines for Millions of Citizens ...Before the FDA Clinical or Safety Reviews Have Been Made Public

BioNTech’s mRNA vaccine works by delivering the genetic code for “neoantigens” to the patient's cells. The code instructs the cells to start producing the neoantigens, which are identical to proteins that are created by the cancer cells. Producing these proteins helps kickstart the immune system so that it begins attacking the cancer itself.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

ForbesTech /  🏆 318. in US

Österreich Neuesten Nachrichten, Österreich Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Breakingviews - GSK castoff starts life with target on its backBreakingviews - GSK castoff starts life with target on its backGlaxoSmithKline’s personal health spinoff is beginning life with a target on its back. Haleon, maker of Advil painkillers and Sensodyne toothpaste, will next month list in London, and could be worth 42 billion pounds. But with two large shareholders keen to sell out, lots of debt and a challenging consumer backdrop, it may not stay single for long.
Weiterlesen »

The New Moderna Vaccine Booster Could Be the 'Turning Point' For the PandemicThe New Moderna Vaccine Booster Could Be the 'Turning Point' For the PandemicA new Moderna vaccine booster, combining the original mRNA vaccine with a vaccine targeting omicron, might be highly effective. It could arrive this fall.
Weiterlesen »

The U.S. May Soon Have Access to Novavax, a Fourth COVID-19 Vaccine OptionThe U.S. May Soon Have Access to Novavax, a Fourth COVID-19 Vaccine OptionThe vaccine could be a game-changer for people who have been holding out for another vaccine option.
Weiterlesen »

Dumbing of Age is an Absolute Gamechanger for Trans RepresentationDumbing of Age is an Absolute Gamechanger for Trans RepresentationThe long-running webcomic Dumbing of Age by damnyouwillis has secretly had a genius detail when depicting its Trans characters that's a massive gamechanger. It all comes down to the eyes.
Weiterlesen »

How the PGA Is Rediscovering Community at the 2022 Produced By ConferenceHow the PGA Is Rediscovering Community at the 2022 Produced By ConferenceBetsy Beers, creative partner at Shondaland and co-chair of the PGA Produced By Conference, outlines this year's event.
Weiterlesen »

Did Chance '98 Meeting at Photocopier Bode End of COVID Pandemic? Ask These 2Did Chance '98 Meeting at Photocopier Bode End of COVID Pandemic? Ask These 2Recognized for the expeditious development of a lifesaving shot, scientists Dr. Katalin Karikó and Dr. Drew Weissman accepted an award in front of dozens of their peers celebrating the duo’s tireless efforts in inventing the mRNA technology behind the COVID-19 vaccine. On Tuesday in Manhattan, in conjunction with the Feinstein Institutes for Medical Research and Molecular Medicine, the Ross Prize…
Weiterlesen »



Render Time: 2025-03-31 10:55:13